- $2.37m
- $3.14m
- $13.79m
CV Sciences Q1 revenue falls 11% on lower sales volume
CV Sciences Q4 sales fall
CV Sciences Q3 revenue falls
Brief: CV Sciences Got Final Arbitration Award From American Arbitration Association Finding Against Michael J. Mona On All Claims For Relief
Brief: CV Sciences Enters Into Definitive Agreement To Acquire Extract Labs
Brief: Cv Sciences reports Q2 results
Brief: CV Sciences Announces Convertible Note Financing
Brief: CV Sciences Reports Third Quarter 2021 Financial Results
Brief: CV Sciences Inc Reports Second Quarter 2021 Financial Results
Brief: Cv Sciences Announces Launch Of PlusCBD Calm and Sleep Gummies
High and rising higher? THC-linked pot stocks outperform sober cousin
Brief: CV Sciences Files For Mixed Shelf Of Up To $100 Million
Brief: Cv Sciences Inc Appoints Paul Blake To Its Board Of Directors
Brief: CV Sciences To Seek Continued Examination Of Its U.S. Patent Application
Brief: CV Sciences Inc Reports Q2 2019 Financial Results
Brief: CV Sciences Announces New Distribution With Kroger
Brief: CV Sciences Reports Q1 Non-GAAP Earnings Per Share $0.01
Brief: CV Sciences Posts Q4 Sales of $14.2 Million
Brief: Cv Sciences Inc Announces The Retirement Of Its Founder And Management Restructure